For health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
The S-ICD System is an established, first-choice therapy that provides protection for patients at risk for sudden cardiac death while avoiding risks and complications associated with transvenous leads.
Transvenous Lead-Related ComplicationsMultiple studies demonstrate that young patients are particularly at risk of lead complications and that patients survive longer than their TV-ICD leads
Transvenous Lead Infections1 year survival curves among TV-ICD patients with pocket infection & endovascular infection following TV-ICD system removal
S-ICD: A New Evolution of Therapy
Transvenous implantable cardiac defibrillators (TV-ICDs) have been extending patients’ lives for years. Now there’s an important evolution: the subcutaneous implantable device (S-ICD) which offers a less invasive solution for patients at risk of sudden cardiac death.